Neuromuscular blocking agents and reversal agents

被引：0

作者：

Ahmad, Shahzaib ^{[1
]}

Handslip, Rhodri ^{[1
]}

机构：

[1] St Georges Univ Hosp NHS Trust, Intens Care Med, London, England

来源：

ANAESTHESIA AND INTENSIVE CARE MEDICINE | 2024年 / 25卷 / 09期

关键词：

Acetylcholine; aminosteroid; benzylisoquinolinium; neostigmine; neuromuscular blocking drugs; neuromuscular junction; succinylcholine; sugammadex;

D O I：

10.1016/j.mpaic.2024.07.001

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

The neuromuscular junction is a complex structure consisting of the muscle cell, the nerve terminal of a motor neuron and the synaptic cleft. It is the site of action for neuromuscular blocking drugs, which are a cornerstone of anaesthetic practice. These drugs can be divided into depolarizing and non-depolarizing drugs; the latter can be further subdivided into benzylisoquinolinium and aminosteroid compounds. Reversal agents are also discussed. The pharmacology of neuromuscular blocking drugs and reversal agents is discussed including mechanism of action, metabolism, factors influencing choice of drug as well as adverse effect profile.

引用

页码：595 / 599

页数：5

共 50 条

[41] Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study [J].

Domenech, Gonzalo ;

Kampel, Matias A. ;

Garcia Guzzo, Maria E. ;

Sanchez Novas, Delfina ;

Terrasa, Sergio A. ;

Garcia Fornari, Gustavo .

BMC ANESTHESIOLOGY, 2019, 19 (01)

[42] Molecular mechanisms of neuromuscular blocking agents: Is the increased understanding of importance to the practising anaesthetist? [J].

Aglan, MY ;

Pollard, BJ .

PHARMACOLOGY & THERAPEUTICS, 1995, 68 (03) :365-383

[43] PROLONGED PARALYSIS AFTER TREATMENT WITH NEUROMUSCULAR-JUNCTION BLOCKING-AGENTS [J].

GOOCH, JL ;

SUCHYTA, MR ;

BALBIERZ, JM ;

PETAJAN, JH ;

CLEMMER, TP .

CRITICAL CARE MEDICINE, 1991, 19 (09) :1125-1131

[44] Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012 [J].

Petitpain, N. ;

Argoullon, L. ;

Masmoudi, K. ;

Fedrizzi, S. ;

Cottin, J. ;

Latarche, C. ;

Mertes, P. M. ;

Gillet, P. .

ALLERGY, 2018, 73 (11) :2224-2233

[45] Is there still a place for fast-acting neuromuscular blockade agents: fast onset or safe and prompt reversal? [J].

Jankovic, Radmilo ;

Stojanovic, Milena ;

Nikolic, Aleksandar .

CURRENT OPINION IN ANESTHESIOLOGY, 2025, 38 (04) :343-348

[46] COMPARISON OF RESIDUAL NEUROMUSCULAR BLOCKADE BETWEEN TWO INTERMEDIATE ACTING NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS - ROCURONIUM AND VECURONIUM [J].

Khan, Shabana ;

Divatia, J., V ;

Sareen, R. .

INDIAN JOURNAL OF ANAESTHESIA, 2006, 50 (02) :115-117

[47] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 17-AZASTEROIDAL NEUROMUSCULAR-BLOCKING AGENTS [J].

VERMA, AK ;

LEE, CY ;

HABTEMARIAM, S ;

HARVEY, AL ;

JINDAL, DP .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (05) :331-338

[48] Nursing Considerations When Using Neuromuscular Blocking Agents to Assist With Intubation A Review of Literature [J].

Blauvelt, Grant ;

Burdick, Kailee ;

Cannon, Emily J. .

CRITICAL CARE NURSING QUARTERLY, 2019, 42 (01) :30-40

[49] Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials [J].

Raval, Amit D. ;

Uyei, Jennifer ;

Karabis, Andreas ;

Bash, Lori D. ;

Brull, Sorin J. .

JOURNAL OF CLINICAL ANESTHESIA, 2020, 64

[50] Comparison between succinylcholine and rocuronium as neuromuscular blocking agents for electroconvulsive therapy in a patient with pseudocholinesterase deficiency [J].

Takazawa, Tomonori ;

Suto, Takashi ;

Aihara, Masako ;

Anzai, Takeshi ;

Horiuchi, Tatsuo ;

Yamada, Makiko H. ;

Kadoi, Yuji ;

Saito, Shigeru .

JA CLINICAL REPORTS, 2015, 1

← 1 2 3 4 5 →